# Exploratory Study to Explore the Safety and Efficacy of the HDx Therapy Using Theranova 500 Dialyzer in Comparison to Hemodiafiltration

> **NCT03499691** · NA · COMPLETED · sponsor: **Vantive Health LLC** · enrollment: 43 (actual)

## Conditions studied

- End Stage Renal Disease

## Interventions

- **DEVICE:** Theranova 500 medium cut-off dialyzer
- **DEVICE:** Hemodiafiltration

## Key facts

- **NCT ID:** NCT03499691
- **Lead sponsor:** Vantive Health LLC
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-04-11
- **Primary completion:** 2018-10-04
- **Final completion:** 2018-10-04
- **Target enrollment:** 43 (ACTUAL)
- **Last updated:** 2025-03-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03499691

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03499691, "Exploratory Study to Explore the Safety and Efficacy of the HDx Therapy Using Theranova 500 Dialyzer in Comparison to Hemodiafiltration". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03499691. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*